Deepening Expertise in Minimally Invasive Ablation and Advancing Academic Excellence: Professor Xiao Yueyong Conducts In-Depth Academic Exchange and Clinical Guidance at Uni-Asia

On July 18, Professor Xiao Yueyong, President of the World Ablation Therapy Association (WATA) and a leading figure in establishing China’s standards for ablation diagnosis and treatment, visited our hospital to conduct specialized academic exchanges and provide clinical guidance. This in-depth academic session not only represented an important initiative to empower the hospital’s specialty development through the expertise of top specialists, but also highlighted the benchmark strength and professional commitment of Chengdu Uni-Asia Cancer Hospital as a WATA Clinical Demonstration Hospital in the field of minimally invasive tumor ablation.

Professor Xiao Yueyong has been deeply engaged in minimally invasive interventional treatment for tumors for more than 40 years. He pioneered conformal cryoablation strategies for tumors, designed more than 20 innovative CT/MRI-guided interventional ablation procedures, led the development and publication of more than 10 expert consensuses and clinical guidelines on minimally invasive tumor ablation, and has received multiple national-level scientific research awards. As a key contributor to China’s standards for ablation diagnosis and treatment, he also enjoys significant influence and a strong voice in the field of minimally invasive tumor diagnosis and treatment worldwide.

Professor Xiao’s academic exchange at the hospital carries profound significance. As a WATA Clinical Demonstration Hospital, Chengdu Uni-Asia Cancer Hospital has consistently been committed to the standardized application and innovative exploration of minimally invasive tumor ablation technologies. Professor Xiao’s visit not only served as an authoritative review of the hospital’s technological capabilities and achievements in specialty development, but also built a direct bridge between the hospital and the forefront of international ablation technologies. During the exchange, Professor Xiao and the hospital’s expert team engaged in in-depth discussions on key topics, including the latest advances in interventional tumor treatment, clinical applications of cryoablation and NanoKnife ablation, strategies for managing complex cases, specialty development, and talent cultivation.

△ Professor Xiao Yueyong (center), Professor Liao Zhengyin (right), and President He Weibing (left) engage in an in-depth discussion

As a WATA Clinical Demonstration Hospital, Chengdu Uni-Asia Cancer Hospital has consistently aligned itself with international cutting-edge standards in oncology diagnosis and treatment, focusing on the development of its specialized discipline in minimally invasive tumor ablation. It is a core medical institution in Southwest China dedicated to the standardized diagnosis and treatment of tumor ablation and technological innovation. Leveraging the advantages of the WATA international platform, the hospital has long been connected with advanced global concepts and technological systems in ablation diagnosis and treatment, establishing a standardized and regulated platform for minimally invasive tumor treatment. With advantages including minimal trauma, faster recovery, high precision, and broad indications, the hospital provides cancer patients with individualized and refined minimally invasive treatment plans, substantially improving the quality of regional cancer care and patient outcomes.

Over the years, with the continuous support and technical leadership of top experts including Professor Xiao Yueyong, Professor Liao Zhengyin, and Professor Zhang Jinshan, the tumor ablation specialty at Chengdu Uni-Asia Cancer Hospital has continued to make breakthroughs and steadily advance. The hospital has maintained a leading position in Southwest China in technological innovation, clinical outcomes, specialty development, academic research, and other areas. It has not only become a model for standardized minimally invasive tumor ablation in the region, but also undertaken the industry responsibility of promoting technological advancement, facilitating academic exchanges, and cultivating medical professionals, continuously advancing the standardized and refined development of minimally invasive tumor ablation in Southwest China.

Taking Professor Xiao Yueyong’s visit as an opportunity, Chengdu Uni-Asia Cancer Hospital will continue to leverage WATA’s high-level international platform, deepen academic exchanges and technical cooperation with leading ablation experts in China and abroad, and continuously enhance its capabilities in minimally invasive tumor ablation. The hospital is committed to providing more cancer patients with precise, safe, and effective treatment options, contributing to the high-quality development of tumor ablation in China with the strength of Uni-Asia.